44 results match your criteria: "Texas Heart Institute and St Luke's Episcopal Hospital[Affiliation]"
Eur Heart J Cardiovasc Imaging
October 2014
Department Cuore e Grossi Vasi Attilio Reale, Sapienza University in Rome, Policlinico Umberto I, Rome, Italy.
Anderson Fabry's disease (AFD) is a rare but underdiagnosed intracellular lipid disorder which can cause left ventricular hypertrophy (LVH). Pre-clinical diagnosis of Fabry's disease is important as it permits early stratification for enzyme replacement therapy, improving the patient's long-term prognosis, avoiding progression to irreversible fibrosis, and preventing cardiovascular complications. Combinations of imaging modalities that integrate the strengths of each modality and at the same time eliminate weaknesses of an individual modality can offer improved diagnostics, therapeutic monitoring, and pre-clinical assessment of Fabry's disease.
View Article and Find Full Text PDFClin Cardiol
May 2013
Texas Heart Institute and St. Luke's Episcopal Hospital, Department of adult cardiiology, Houston, Texas, USA.
The concept of electrical protection of the ischemic myocardium is in constant evolution and has recently been supported by experimental and clinical studies. Historically, antiplatelet agents, angiotensin-converting enzyme inhibitors, β-blockers, and statins have been all proposed as drugs conferring anti-ischemic cardioprotection. This was supported by the evidence consistently indicating that all these drugs were capable of reducing mortality and the risk of repeat myocardial infarction.
View Article and Find Full Text PDFDiastolic segmental compression of a native coronary artery is an uncommon cause of chest pain. Here we describe a 24-year-old woman with constrictive pericarditis who had retrosternal chest pain, progressive dyspnea, tachycardia, and bilateral leg edema. She was diagnosed with compression of the first and second obtuse marginal branches of left circumflex coronary artery secondary to constrictive pericarditis.
View Article and Find Full Text PDFTex Heart Inst J
August 2006
The Neurology Service, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
Acute anterior spinal cord ischemia is a rare but disastrous complication of endovascular aortic procedures. Although intravenous thrombolysis with recombinant tissue plasminogen activator is an effective treatment for acute brain ischemia, its use for the treatment of spinal cord ischemia has not previously been reported. We report the case of a patient who developed anterior spinal cord ischemia during diagnostic aortography He was treated with intravenous recombinant tissue plasminogen activator within 3 hours after the onset of symptoms.
View Article and Find Full Text PDFJ Endovasc Ther
February 2006
Department of Cardiovascular Surgery, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
Purpose: To present a case of delayed abdominal aortic aneurysm (AAA) re-expansion after thrombolysis for endograft limb occlusion.
Case Report: A 68-year-old man underwent AAA exclusion with an AneuRx stent-graft in 1999. Five years later, he developed right limb thrombosis of the endograft.
Tex Heart Inst J
January 2006
Peripheral Vascular Disease Service, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
From my point of view, carotid artery stenting, in 2005, is clearly here to stay. "Houston, the Eagle has landed." The rest is up to you and me as we encourage our surgical colleagues and our various medical Societies to embrace this safe, effective, and durable technology and make it available to the patients who will really benefit from it.
View Article and Find Full Text PDFTex Heart Inst J
January 2006
Department of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
Tex Heart Inst J
October 2005
Department of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, TX 77030, USA.
J Card Surg
December 2005
Department of Cardiovascular Anesthesiology, The Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, TX, USA.
Background: The use of left ventricular (LV) assist devices (LVADs) can improve performance and recovery of failing human hearts.
Aim: Following our alpha-adrenergic receptor work, we hypothesized that mechanical unloading in patients with low output syndrome and LV failure would yield similar results with beta-adrenergic receptors ((beta)AR), that being increased numbers and intra-myocytic relocalization.
Methods: (beta)AR density and localization were investigated by fluorescence deconvolution microscopy and compared at LVAD insertion and removal in 13 heart failure patients, the patients therefore acting as their own control.
J Heart Lung Transplant
June 2005
Department of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77225-0345, USA.
West Nile virus is a mosquito-borne RNA Flavivirus infection transmitted to humans and other vertebrates, mainly by the Culex species of mosquito. Since the mid-1990s, the frequency and apparent clinical severity of West Nile virus outbreaks have increased. We report the case of a patient who developed West Nile virus encephalitis shortly after undergoing cardiac transplantation.
View Article and Find Full Text PDFJ Heart Lung Transplant
December 2003
Department of Pathology, Texas Heart Institute and St. Luke's Episcopal Hospital, 6720 Bertner, Houston, TX 77030, USA.
Background: Left ventricular assist devices (LVADs) currently are used as bridges for patients who deteriorate clinically while awaiting cardiac transplantation. At the time of transplantation or subsequent death, we can assess the effect of long-term device implantation on cardiac structural changes. We have noted, in our years of experience, that aortic valve commissures may fuse in patients supported by LVADs.
View Article and Find Full Text PDFTex Heart Inst J
October 2003
Departments of Transplantation and Heart Failure, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
Phosphodiesterase inhibitors such as milrinone can relieve symptoms and improve hemodynamics in patients with advanced congestive heart failure. We retrospectively evaluated the hemodynamic and clinical outcomes of long-term combination therapy with intravenous milrinone and oral beta-blockers in 65 patients with severe congestive heart failure (New York Heart Association class IV function and ejection fraction <25%) refractory to oral medical therapy. Fifty-one patients successfully began beta-blocker therapy while on intravenous milrinone.
View Article and Find Full Text PDFAnn Thorac Surg
March 2003
Cardiovascular Surgical Research, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77225-0345, USA.
In this report, we describe successful implantation of a Jarvik 2000 left ventricular assist device (Jarvik Heart, Inc, New York, NY) without the use of cardiopulmonary bypass in a patient who was a member of the Jehovah's Witness faith. To accomplish this, we had to change our implantation technique. The modified technique, which minimizes the risk of bleeding and end-organ dysfunction, can also be used to decrease cardiopulmonary bypass time.
View Article and Find Full Text PDFTex Heart Inst J
June 2003
Department of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, and Baylor College of Medicine, Houston, Texas 77030, USA.
Tex Heart Inst J
June 2003
The Department of Cardiology and Electrophysiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston, Texas 77030, USA.
In the United States, physicians adapt currently available defibrillators to accommodate leads for biventricular pacing in those congestive heart failure patients who might benefit from cardiac resynchronization and who are additionally at risk for sudden cardiac death. The adaptation of the lead system of available defibrillators to also allow them to function as biventricular pacemakers presents occasions in which inappropriate shocks are delivered due to double counting of the right and left ventricular depolarizations by the implantable cardiac defibrillator. We reviewed a series of inappropriate shock deliveries that occurred after the implantation of biventricular pacing cardiac defibrillators at our institution; all of these shocks were related to ventricular double counting.
View Article and Find Full Text PDFTex Heart Inst J
October 2002
Department of Cardiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston 77030, USA.
We used the Texas Heart Institute Cardiovascular Research Database to retrospectively identify patients who had undergone their 1st revascularization procedure with coronary artery bypass surgery (CABG; n=2,826) or coronary stenting (n=2,793) between January 1995 and December 1999. Patients were classified into 8 anatomic groups according to the number of diseased vessels and presence or absence of proximal left anterior descending coronary artery disease. Mortality rates were adjusted with proportional hazards methods to correct for baseline differences in severity of disease and comorbidity.
View Article and Find Full Text PDFTex Heart Inst J
March 2002
Department of Adult Cardiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston 77030, USA.
Subendocardial ischemia as indicated by electrocardiography during exercise, in association with severe systolic anterior motion of the anterior mitral valve leaflet without left ventricular hypertrophy, has not been well described. We report the case of a 42-year-old man who presented with symptoms of exertional angina and 2-mm ST depression on treadmill electrocardiography but had a normal perfusion scan and coronary angiogram. Initially the negative angiographic results caused us to regard the treadmill results as false-positive.
View Article and Find Full Text PDFTex Heart Inst J
March 2002
Section of Adult Cardiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston 77030, USA.
We reviewed recent clinical data on the management of unstable angina and non-ST segment elevation myocardial infarction. We concentrated on the use of new therapies, particularly in combination with both older agents and other new methods, in order to present health care providers with an overview of available treatment options. The clinical trials reviewed herein provide strong evidence and proof of principle that combination therapies targeting 1) platelet function (aspirin, thienopyridines, and GP IIb/IIIa antagonists), 2) the coagulation cascade (unfractionated heparin and low-molecular-weight heparin), and 3) the physical characteristics of the active lesion (percutaneous intervention) reduce the risk of death or ischemic complications after thrombotic progression of coronary atherosclerosis.
View Article and Find Full Text PDFTex Heart Inst J
March 2002
Department of Cardiology, Clinical Cardiac Electrophysiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston 77030, USA.
The incidence of certain clinical arrhythmias varies between and women. Clinical and experimental observations suggest the existence of true differences in electrophysiologic properties between the sexes. We review these differences, possible mechanisms, clinical implications, and therapeutic considerations in the treatment of various arrhythmias in women.
View Article and Find Full Text PDFTex Heart Inst J
February 2002
Texas Heart Institute and St Luke s Episcopal Hospital Houston, 77225-0345, USA.
Mycosis fungoides, an uncommon form of cutaneous T-cell lymphoma, arises in the skin and frequently progresses to generalized lymphadenopathy Although the cause of cutaneous T-cell lymphoma is unknown, chronic immunosuppression may play a role. A few cases have been reported in renal transplant recipients; however, ours appears to be the 1st report of cutaneous T-cell lymphoma in a cardiac transplant recipient. In our patient, cutaneous manifestations of the disease were noted less than 1 year after transplantation.
View Article and Find Full Text PDFTex Heart Inst J
December 2000
The Department of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, USA.
Surgical treatment of carotid restenosis and radiation-induced occlusive disease is challenging because of the high morbidity and mortality associated with this procedure. Carotid stenting has been proposed as an alternative approach. We report a series of 8 patients who were treated via the percutaneous approach for either carotid restenosis (n = 4) or radiation-induced occlusive disease (n = 4).
View Article and Find Full Text PDFJ Endovasc Surg
May 1999
Department of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, USA.
Purpose: To report early experience using a vascular closure device following endovascular aortic aneurysmal repair in which large-bore sheaths are used.
Technique: A 10F Prostar XL Percutaneous Vascular Surgery device is used to deploy sutures around sheath entry sites up to 16F. At the completion of the procedure, the sutures are tied with a sliding knot to ensure adequate hemostasis.
J Am Soc Echocardiogr
May 1999
Department of Cardiology, Texas Heart Institute and St Luke's Episcopal Hospital, Houston, Tex. 77030, USA.
Although an acquired subaortic membrane has been reported as a cause of left ventricular outflow tract (LVOT) obstruction in various clinical settings, it previously has not been reported after mitral valve surgery. We describe 3 cases of acquired LVOT obstruction that resulted from development of a subaortic membrane after mitral valve replacement. This report emphasizes the role of an acquired subaortic membrane in LVOT obstruction after mitral valve replacement, the use of echocardiography in diagnosing this condition, and the importance of early intervention.
View Article and Find Full Text PDFTex Heart Inst J
February 2005
The Division of Cardiology, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas 77225, USA.